EAP and COVID-19: Return to Work Safely Protocol: COVID-19 Specific National Protocol for Employers and Workers
AuthorGovernment of Ireland. Department of Business, Enterprise and Innovation and the Department of Health
MetadataShow full item record
Other TitlesReturn to Work Safely Protocol: COVID-19 Specific National Protocol for Employers and Workers
AbstractWe are all confronted with a situation that was unimaginable a few short weeks ago. The COVID-19 pandemic has impacted severely on every part of our society and our economy. In the face of this, the biggest challenge we have encountered in decades, Irish people have almost universally stepped up to the plate and adhered to the strict guidelines put in place by the Government, following the advice of the National Public Health Emergency Response Team (NPHET). Because of this strict adherence to the rules, we have all contributed to the progress that Ireland has made in containing the spread of COVID-19 and, in so doing, we have saved lives. Now, because of the progress made, we are beginning to move to the next phase in reducing the spread of the virus, while starting to gradually re-open our economy and our society. In doing so, we still need to make sure that we adhere to the rules of the new way of living and working, so that we maintain the gains we have made, and continue to suppress the spread of the virus. Work is a key part of life and most of us want to return to our jobs as soon as possible. But we need to get back to work safely.
Table of ContentsA. Introduction ....ii ; B. Protocol for Employers and Workers Regarding the Measures to Prevent the Spread of COVID-19 in the Workplace ...1 ; C. Employer-Worker Engagement, Communication and Training...2 ; D. Background .....3 ; E. Getting Back to Work – Steps for Employers and Workers to Reduce Risk of Exposure to COVID-19 in the Workplace...5
DescriptionIrish Government Document on Return To Work Policies
SponsorsPrepared by the Department of Business, Enterprise and Innovation and the Department of Health
Rights/TermsAttribution-NonCommercial-NoDerivatives 4.0 International
Coronavirus Disease 2019 (COVID-19)
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/13283
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Showing items related by title, author, creator and subject.
EAP and COVID-19: Work Safely Protocol: COVID-19 National Protocol for Employers and WorkersGovernment of Ireland (2020-11-20)The COVID-19 pandemic has affected every part of Ireland’s society and economy. In the face of this, the biggest challenge we have encountered in decades, the people of Ireland have universally stepped up to the plate and adhered to the strict guidelines put in place by the Government, following the advice of the National Public Health Emergency Team (NPHET). We have all contributed to the progress that Ireland has made in containing the spread of COVID-19 and in so doing we have saved lives. However, our continued progress in reducing the spread of the virus remains challenging. We collectively and individually need to continue our efforts to keep the virus under control. The revision of the Return to Work Safely Protocol has become necessary to ensure that it reflects the Government’s Resilience and Recovery 2020-2021: Plan for Living with COVID- 19 as well as updating the public health advice available since its first publication. This revised document is now called the Work Safely Protocol. It continues to be designed to support employers and workers to put infection prevention and control (IPC) and other measures in place to prevent the spread of COVID-19 in the workplace. The Work Safely Protocol also covers the measures needed to both ensure the safe operation of workplaces and the re- opening of workplaces following temporary closure due to local and regional restrictions.
Effectiveness of Iodophor vs Chlorhexidine Solutions for Surgical Site Infections and Unplanned Reoperations for Patients Who Underwent Fracture Repair: The PREP-IT Master ProtocolSlobogean, G.P.; Harris, A.D.; Mullins, D.C.; Joshi M.G.; Program of Randomized Trials to Evaluate Pre-operative Antiseptic Skin Solutions in Orthopaedic Trauma (PREP-IT) Investigators (American Medical Association, 2020)Importance: The risk of developing a surgical site infection after extremity fracture repair is nearly 5 times greater than in most elective orthopedic surgical procedures. For all surgical procedures, it is standard practice to prepare the operative site with an antiseptic solution; however, there is limited evidence to guide the choice of solution used for orthopedic fracture repair. Objective: To compare the effectiveness of iodophor vs chlorhexidine solutions to reduce surgical site infections and unplanned fracture-related reoperations for patients who underwent fracture repair. Design, Setting, and Participants: The PREP-IT (Program of Randomized Trials to Evaluate Pre-operative Antiseptic Skin Solutions in Orthopaedic Trauma) master protocol will be followed to conduct 2 multicenter pragmatic cluster randomized crossover trials, Aqueous-PREP (Pragmatic Randomized Trial Evaluating Pre-Operative Aqueous Antiseptic Skin Solution in Open Fractures) and PREPARE (Pragmatic Randomized Trial Evaluating Pre-Operative Alcohol Skin Solutions in Fractured Extremities). The Aqueous-PREP trial will compare 4% aqueous chlorhexidine vs 10% povidone-iodine for patients with open extremity fractures. The PREPARE trial will compare 2% chlorhexidine in 70% isopropyl alcohol vs 0.7% iodine povacrylex in 74% isopropyl alcohol for patients with open extremity fractures and patients with closed lower extremity or pelvic fractures. Both trials will share key aspects of study design and trial infrastructure. The studies will follow a pragmatic cluster randomized crossover design with alternating treatment periods of approximately 2 months. The primary outcome will be surgical site infection and the secondary outcome will be unplanned fracture-related reoperations within 12 months. The Aqueous-PREP trial will enroll a minimum of 1540 patients with open extremity fractures from at least 12 hospitals; PREPARE will enroll a minimum of 1540 patients with open extremity fractures and 6280 patients with closed lower extremity and pelvic fractures from at least 18 hospitals. The primary analyses will adhere to the intention-to-treat principle and account for potential between-cluster and between-period variability. The patient-centered design, implementation, and dissemination of results are guided by a multidisciplinary team that includes 3 patients and other relevant stakeholders. Discussion: The PREP-IT master protocol increases efficiency through shared trial infrastructure and study design components. Because prophylactic skin antisepsis is used prior to all surgical procedures and the application, cost, and availability of all study solutions are similar, the results of the PREP-IT trials are poised to inform clinical guidelines and bring about an immediate change in clinical practice. Trial Registration: ClinicalTrials.gov Identifiers: NCT03385304 and NCT03523962.
An EAP intervention protocol for occupational health nurses.Csiernik, Rick (American Association of Occupational Health Nurses, 1990-09-02)A formal intervention protocol for occupational health nurses in provided focusing on knowledge and skills required when providing EAP counselling.